These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 18566118
1. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2. Barbieri F, Pattarozzi A, Gatti M, Porcile C, Bajetto A, Ferrari A, Culler MD, Florio T. Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118 [Abstract] [Full Text] [Related]
2. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. Barbieri F, Pattarozzi A, Gatti M, Aiello C, Quintero A, Lunardi G, Bajetto A, Ferrari A, Culler MD, Florio T. Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1078-88. PubMed ID: 19706788 [Abstract] [Full Text] [Related]
3. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2. Massa A, Barbieri F, Aiello C, Iuliano R, Arena S, Pattarozzi A, Corsaro A, Villa V, Fusco A, Zona G, Spaziante R, Schettini G, Florio T. Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806 [Abstract] [Full Text] [Related]
4. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Buscail L, Estève JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, Bell GI, Schally AV, Vaysse N, Susini C. Proc Natl Acad Sci U S A; 1995 Feb 28; 92(5):1580-4. PubMed ID: 7878022 [Abstract] [Full Text] [Related]
6. Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20. Tallent M, Liapakis G, O'Carroll AM, Lolait SJ, Dichter M, Reisine T. Neuroscience; 1996 Apr 28; 71(4):1073-81. PubMed ID: 8684611 [Abstract] [Full Text] [Related]
7. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD, degli Uberti EC. J Clin Endocrinol Metab; 2001 May 28; 86(5):2161-9. PubMed ID: 11344221 [Abstract] [Full Text] [Related]
8. The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation. Massa A, Barbieri F, Aiello C, Arena S, Pattarozzi A, Pirani P, Corsaro A, Iuliano R, Fusco A, Zona G, Spaziante R, Florio T, Schettini G. J Biol Chem; 2004 Jul 09; 279(28):29004-12. PubMed ID: 15123617 [Abstract] [Full Text] [Related]
9. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2. Florio T, Thellung S, Arena S, Corsaro A, Bajetto A, Schettini G, Stork PJ. J Physiol Paris; 2000 Jul 09; 94(3-4):239-50. PubMed ID: 11088001 [Abstract] [Full Text] [Related]
12. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Buscail L, Delesque N, Estève JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV. Proc Natl Acad Sci U S A; 1994 Mar 15; 91(6):2315-9. PubMed ID: 7907795 [Abstract] [Full Text] [Related]
13. Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells. Chen L, Fitzpatrick VD, Vandlen RL, Tashjian AH. J Biol Chem; 1997 Jul 25; 272(30):18666-72. PubMed ID: 9228036 [Abstract] [Full Text] [Related]
15. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Florio T, Rim C, Hershberger RE, Loda M, Stork PJ. Mol Endocrinol; 1994 Oct 25; 8(10):1289-97. PubMed ID: 7854346 [Abstract] [Full Text] [Related]
16. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide. Jaquet P, Gunz G, Saveanu A, Barlier A, Dufour H, Taylor J, Dong J, Kim S, Moreau JP, Culler MD. J Endocrinol Invest; 2005 Oct 25; 28(11 Suppl International):21-7. PubMed ID: 16625841 [Abstract] [Full Text] [Related]
17. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes. Jaquet P, Saveanu A, Gunz G, Fina F, Zamora AJ, Grino M, Culler MD, Moreau JP, Enjalbert A, Ouafik LH. J Clin Endocrinol Metab; 2000 Feb 25; 85(2):781-92. PubMed ID: 10690891 [Abstract] [Full Text] [Related]
18. Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. Florio T, Barbieri F, Spaziante R, Zona G, Hofland LJ, van Koetsveld PM, Feelders RA, Stalla GK, Theodoropoulou M, Culler MD, Dong J, Taylor JE, Moreau JP, Saveanu A, Gunz G, Dufour H, Jaquet P. Endocr Relat Cancer; 2008 Jun 25; 15(2):583-96. PubMed ID: 18509006 [Abstract] [Full Text] [Related]